Avalo Therapeutics, Inc. (AVTX)

Avalo Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	81.86	7.42	13.17	54.59	18.92	3.61
Cash & Short-Term Investments	81.86	7.42	13.17	54.59	18.92	3.61
Cash Growth	704.11%	-43.71%	-75.87%	188.52%	424.15%	-66.10%
Accounts Receivable	-	-	-	1.06	2.18	1
Other Receivables	1	0.14	1.92	3.74	2.21	0.14
Receivables	1	0.14	1.92	4.8	4.39	5.24
Inventory	-	-	0.02	0.04	0	0.02
Prepaid Expenses	3.25	0.84	1.29	2.37	2.66	0.71
Restricted Cash	0.04	0	0.02	0.05	0.04	0.02
Other Current Assets	-	-	-	-	-	8.13
Total Current Assets	86.15	8.4	16.42	61.85	26.01	17.72
Property, Plant & Equipment	1.67	1.97	2.41	2.7	1.61	1.45
Goodwill	10.5	10.5	14.41	14.41	14.41	14.41
Other Intangible Assets	-	-	-	0.04	1.59	2.43
Other Long-Term Assets	0.13	0.13	0.13	1.23	0.15	0.1
Total Assets	98.46	20.99	33.37	80.21	43.76	36.11
Accounts Payable	1.81	0.45	2.88	3.37	2.57	2.08
Accrued Expenses	3.59	1.76	10.51	14.29	8.86	3.11
Current Portion of Long-Term Debt	-	-	5.93	-	-	-
Current Portion of Leases	0.55	0.54	0.53	0.49	0.43	0.16
Current Income Taxes Payable	-	-	-	-	-	0.55
Current Unearned Revenue	-	-	0.09	-	-	-
Other Current Liabilities	54.72	1.87	2.17	1.74	3.36	6.26
Total Current Liabilities	60.67	4.62	22.11	19.89	15.23	12.16
Long-Term Debt	-	-	13.49	32.83	-	-
Long-Term Leases	1.08	1.37	1.71	2.02	1.04	1.11
Long-Term Deferred Tax Liabilities	0.15	0.16	0.14	0.11	0.09	0.09
Other Long-Term Liabilities	13.81	7.55	6.83	2.28	2.84	1.76
Total Liabilities	75.72	13.69	44.28	57.13	19.19	15.11
Common Stock	0.01	0	-	0.01	0.08	0.05
Additional Paid-In Capital	355.99	342.44	292.91	285.24	202.28	135.24
Retained Earnings	-334.92	-335.13	-303.82	-262.17	-177.79	-114.29
Total Common Equity	21.08	7.3	-10.92	23.08	24.56	21
Shareholders' Equity	22.73	7.3	-10.92	23.08	24.56	21
Total Liabilities & Equity	98.46	20.99	33.37	80.21	43.76	36.11
Total Debt	1.63	1.9	21.66	35.34	1.46	1.27
Net Cash (Debt)	80.23	5.51	-8.49	19.25	17.46	2.34
Net Cash Growth	879.79%	-	-	10.28%	645.41%	-78.00%
Net Cash Per Share	38.75	19.85	-216.49	531.87	684.21	117.97
Filing Date Shares Outstanding	10.39	1.03	0.06	0.04	0.56	1.22
Total Common Shares Outstanding	9.68	0.8	0.04	0.04	0.55	1.22
Working Capital	25.47	3.78	-5.7	41.96	10.78	5.56
Book Value Per Share	2.18	9.11	-277.78	589.35	44.33	17.27
Tangible Book Value	10.57	-3.2	-25.32	8.64	8.57	4.16
Tangible Book Value Per Share	1.09	-3.99	-644.47	220.48	15.46	3.42
Machinery	-	0.28	0.34	0.24	0.21	0.15
Leasehold Improvements	-	0.9	0.74	0.74	0.66	0.66

Source: S&P Capital IQ. Standard template. Financial Sources.